NEOPAR is a modified-live canine parvovirus vaccine. NEOPAR contains a high antigen mass (more vaccine units per dose), which results in a short period from vaccination to protection, a high level of protection, and long duration of immunity. NEOPAR provides reliable protection against infections by other known strains of canine parvovirus.
